Skip to main content
. 2024 Jan 17;81(4):357–365. doi: 10.1001/jamapsychiatry.2023.5060

Table 2. Characteristics of Included Patients and Trials.

Value No.
Patient characteristics
Age, mean (SD), y 45.4 (16.6) 236 Trials
Sex, No. (%)
Female 21 048/31 452 (67) 232 Trials
Male 10 404/31 452 (33)
Hypnotic use, No. (%) 4259/20 704 (21) 167 Trials
Comorbidities, type Primary insomnia 60 Trials
Psychotic comorbidities 42 Trials
Physical comorbidities 75 Trials
Mixed 64 Trials
Baseline severity (ISI score), mean (SD) 16.8 (4.8) 163 Trials
Diagnosis Formal operationalized criteria 146 Trials
Elevated score 70 Trials
Others 25 Trials
Trial characteristics
Region North America 120 Trials
Europe 61 Trials
Asia 34 Trials
Oceania 14 Trials
Middle East 8 Trials
South America 3 Trials
Africa 1 Trial
No. of arms 2 206 Trials
3 26 Trials
4 7 Trials
5 1 Trial
6 1 Trial
Randomization unit Individual 224 Trials
Cluster 2 Trials
Publication year, mean (range) 2015 (1980-2023) 241 Trials
Intervention Total 528 Arms
Treatment level Cognitive behavioral therapy 210 Arms
Behavioral therapy 64 Arms
Cognitive therapy 17 Arms
Relaxation therapy 16 Arms
Psychoeducation 105 Arms
Attention or psychological placebo 5 Arms
Treatment as usual 8 Arms
No treatment 5 Arms
Waiting list 98 Arms
Components
Educational components Sleep hygiene education 324 Arms
Sleep diary 433 Arms
Cognitive components Cognitive restructuring 203 Arms
Third-wave components 58 Arms
Constructive worry 21 Arms
Behavioral components Sleep restriction 244 Arms
Stimulus control 249 Arms
Paradoxical intention 20 Arms
Relaxation 174 Arms
Others Nonspecific treatment effect 423 Arms
Waiting component 102 Arms
Delivery methods Individual 228 Arms
Group 100 Arms
In person 287 Arms
Online therapeutic guidance 39 Arms
Human encouragement 49 Arms
Automatic encouragement 41 Arms

Abbreviation: ISI, Insomnia Severity Index.